Skip to content
WeighLab
Menu
Ranked #304 · Grade C

Fitstry review

Fitstry is the GLP-1 weight-loss telehealth program of Weightstry, LLC (fitstry.com redirects to weightstry.com/fitstry).

Visit Fitstry Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$249/mo (plus a separate fee, compounded)
Tirzepatide
$339/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,988

Tirzepatide · modeled / year

$4,068

Pricing verified August 2026

The Index scorecard

Fitstry scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month39/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options77/100
Clinical Oversight81/100
Contract Flexibility55/100

Where the value is

  • Named medical director disclosed (Dr. Sergio Naccarato, MD)
  • Licensed in 49 states with LegitScript certification
  • Drug pricing appears stable/recurring rather than a disguised promo rate
  • First month refunded if a clinician denies approval, reducing shopper risk

The tradeoffs

  • No compounding pharmacy partner named
  • Not available in Louisiana (waitlist only)
  • Tirzepatide at $339/month is on the higher end versus other compounded telehealth options
  • Brand identity is split across two domains (fitstry.com / weightstry.com), which can confuse shoppers

The bottom line

Best for: Shoppers who want a named medical director and stable, non-promo monthly pricing. Fitstry is the GLP-1 weight-loss telehealth program of Weightstry, LLC (fitstry.com redirects to weightstry.com/fitstry).

Ranked #304 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Fitstry.

The 24 programs nearest this one

Pricing, states and verification reflect Fitstry's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Fitstry's site. Not medical advice; see our disclosure.

← Back to the value leaderboard